AI Article Synopsis
- The text examines the effects of COVID-19 on paracoccidioidomycosis (PCM) in Argentina, noting that 285 confirmed PCM cases were reported from 2018 through three years post-pandemic declaration.
- It highlights that there was no confirmed link between COVID-19 and PCM, but PCM cases dropped significantly in 2020 due to pandemic-related factors.
- The pandemic caused delays in PCM diagnosis and treatment due to social isolation and mental health issues, raising concerns about potential underdiagnosis because of symptom overlap and insufficient diagnostic methods.
Article Abstract
The impact of COVID-19 on paracoccidioidomycosis (PCM) in Argentina and the consequences generated by the pandemic are discussed. From 2018 to 3 years after the pandemic declaration, 285 proven PCM patients were registered. No association between both diseases was documented. PCM frequency decreased to extremely low levels in 2020. Mandatory social isolation and the emotional and psychological effects generated under pandemic circumstances led to delays in diagnosis, severe disseminated cases, and other challenges for diagnosis in subsequent years. Probable underdiagnosis should be considered due to the overlap of clinical manifestations, the low index of suspicion and the lack of sensitive diagnostic tools.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/myc.13761 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!